
    
      Patients who fulfill eligibility criteria will be entered into the trial to receive ML0N128.
      The participant will be given a study drug-dosing diary for each treatment cycle. After the
      screening procedures confirm participation in the research study.

      - MLN0128 - Fixed doses daily per treatment cycle

      The treatment cycles will continue until the participants disease gets worse or is taken off
      treatment for any other reason.Once treatment has been discontinued the investigators will
      check on the participants health status by phone for the rest of their life.
    
  